During the past decade, Pecsi Tudomanyegyetem AOK; Borgyogyaszati Klinika conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Pecsi Tudomanyegyetem AOK; Borgyogyaszati Klinika" are "Dermatitis, Atopic" (2 trials), "Advanced BRAFV600 Wild-type Melanoma" (1 trials), "Cancer" (1 trials), "Malignant Melanoma" (1 trials) and "Plaque Psoriasis" (1 trials). Many other conditions were trialed in "Pecsi Tudomanyegyetem AOK; Borgyogyaszati Klinika" in a lesser frequency.

Most popular intervention types in "Pecsi Tudomanyegyetem AOK; Borgyogyaszati Klinika" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Placebo" (2 trials), "Abrocitinib 100 mg" (1 trials), "Abrocitinib 200 mg" (1 trials) and "CP-690,550" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pecsi Tudomanyegyetem AOK; Borgyogyaszati Klinika" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Pecsi Tudomanyegyetem AOK; Borgyogyaszati Klinika". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Pecsi Tudomanyegyetem AOK; Borgyogyaszati Klinika, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pecsi Tudomanyegyetem AOK; Borgyogyaszati Klinika, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".